Novo Nordisk raises guidance after beating analysts' expectations
This article was originally published in Scrip
Executive Summary
Novo Nordiskhas raised its full-year operating profit guidance by around 10 percentage points and has reported a 7% sales increase to DKK11.25 billion ($1.94 billion) in the third quarter.